In-biofilm generation of nitric oxide using a magnetically-targetable cascade-reaction container for eradication of infectious biofilms.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35386819.
- Also identified by DOI 10.1016/j.bioactmat.2022.01.044 and PMC identifier 8964971.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cascade-reaction chemistry can generate reactive-oxygen-species that can be used for the eradication of infectious biofilms. However, suitable and sufficient oxygen sources are not always available near an infection site, while the reactive-oxygen-species generated are short-lived. Therefore, we developed a magnetic cascade-reaction container composed of mesoporous Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles containing glucose-oxidase and l-arginine for generation of reactive-oxygen-species. Glucose-oxidase was conjugated with APTES facilitating coupling to Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles and generation of H<sub>2</sub>O<sub>2</sub> from glucose. l-arginine was loaded into the nanoparticles to generate NO from the H<sub>2</sub>O<sub>2</sub> generated. Using an externally-applied magnetic field, cascade-reaction containers could be homogeneously distributed across the depth of an infectious biofilm. Cascade-reaction containers with coupled glucose-oxidase were effective in killing planktonic, Gram-positive and Gram-negative bacteria. Additional efficacy of the l-arginine based second cascade-reaction was only observed when H<sub>2</sub>O<sub>2</sub> as well as NO were generated in-biofilm. <i>In vivo</i> accumulation of cascade-reaction containers inside abdominal <i>Staphylococcus aureus</i> biofilms upon magnetic targeting was observed real-time in living mice through an implanted, intra-vital window. Moreover, vancomycin-resistant, abdominal <i>S. aureus</i> biofilms could be eradicated consuming solely endogenous glucose, without any glucose addition. Herewith, a new, non-antibiotic-based infection-control strategy has been provided, constituting a welcome addendum to the shrinking clinical armamentarium to control antibiotic-resistant bacterial infections.